Schonfeld Strategic Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-67,954	Closed	-$3.11M	–	1077
2017 Q4	$3.11M	Buy	67,954 +59,231	+679%	+$2.95M	0.25%	116
2017 Q3	$391K	Buy	+8,723	New	+$297K	0.04%	414
2017 Q2	–	Sell	-20,376	Closed	-$452K	–	872
2017 Q1	$452K	Buy	+20,376	New	+$437K	0.05%	387
2016 Q3	–	Sell	-10,039	Closed	-$385K	–	615
2016 Q2	$385K	Buy	+10,039	New	+$417K	0.09%	278

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Schonfeld Strategic Advisors's JUNO Position: Q1 2018 in Review

Schonfeld Strategic Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 67,954 shares — an estimated $3.11M sold.

Schonfeld Strategic Advisors first reported a position in JUNO in Q2 2016 and held it in 4 quarters. The position peaked at $3.11M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Schonfeld Strategic Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Schonfeld Strategic Advisors sold 67,954 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $3.11M.
Schonfeld Strategic Advisors first reported a position in Juno Therapeutics, Inc. in Q2 2016 and held it in 4 quarters.
Schonfeld Strategic Advisors's Juno Therapeutics, Inc. position peaked at $3.11M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2018, filed 15 May 2018.